Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects.

Kim, Heeyoung; Kim, Choon Ok; Park, Hyeonsoo; Park, Min Soo; Kim, Dasohm; Hong, Taegon; Shin, Yesong; Jin, Byung Hak

Kim, Heeyoung; Kim, Choon Ok; Park, Hyeonsoo; Park, Min Soo; Kim, Dasohm; Hong, Taegon; Shin, Yesong; Jin, Byung Hak.

Afiliação

Kim H; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Kim CO; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Park H; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Park MS; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Kim D; Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University College of Medicine and Pharmacy, Incheon 21983, Korea.
Hong T; Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, Korea.
Shin Y; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Jin BH; Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.

Transl Clin Pharmacol ; 31(1): 59-68, 2023 Mar.

Article em En | MEDLINE | ID: mdl-37034122

Palavras-chave

Diabetes Mellitus; Drug Interactions; Pharmacokinetics; Thiazolidinediones

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Transl Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article